(Total Views: 186)
Posted On: 05/06/2017 10:12:46 AM
Post# of 8479
INNV - 15M guidance for 2017 (revenue) - came in at 4.8M for all of 2016. 3+x more revenue projected. 150.53M o/s. Trading ~11 cents
Q1 Earnings late next week. Solid product lineup - awaiting FDA decision on FlutiCare which will give Flonase (GSK) a run for the money. Not much downside at 11 cents folks. INNV
Q1 Earnings late next week. Solid product lineup - awaiting FDA decision on FlutiCare which will give Flonase (GSK) a run for the money. Not much downside at 11 cents folks. INNV
(1)
(0)
